Clinical Impact of New Rheumatoid Arthritis Data from APLAR 2019, JCR 2019, and EULAR 2019*

APLAR 2019: Brisbane, Australia; April 8-11, 2019; JCR: Kyoto, Japan; April 15-17, 2019
EULAR: Madrid, Spain; June 12-15, 2019
Review the latest RA management data with Capsule Summaries, downloadable slides, and expert analysis covering key studies from APLAR 2019, JCR 2019, and EULAR 2019.
Leonard H. Calabrese, DO
Paul Emery, MA, MD, FRCP

Rheumatoid Arthritis

Slidesets EXTEND Open-Label Extension: Withdrawal of csDMARDs in Patients With Rheumatoid Arthritis Receiving Sarilumab
Slidesets Randomized Phase III Trial of IV Pegylated Liposomal Prednisolone vs IM Methylprednisolone for Rheumatoid Arthritis Flares
Slidesets FINCH 1: Phase III Trial of Filgotinib in Patients With Rheumatoid Arthritis With Inadequate Response to Methotrexate
Slidesets FINCH 3: Phase III Trial of Filgotinib ± Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis
Slidesets ORAL Shift: Withdrawal of Methotrexate in Patients With Rheumatoid Arthritis Who Achieved Low Disease Activity With Tofacitinib Plus Methotrexate
Slidesets SEMIRA: Tapering of Prednisone in Patients With Rheumatoid Arthritis Who Achieved Low Disease Activity or Remission With Tocilizumab
Slidesets Subcutaneous vs Intravenous Administration of CT-P13 for Rheumatoid Arthritis: Part 2 of Randomized Phase I/III Trial
Slidesets Long-Term Safety of Baricitinib in Patients with Rheumatoid Arthritis: Updated Findings from All-BARI-RA Analysis Set
Slidesets SELECT Pooled Analysis: Safety of Upadacitinib in Patients With Rheumatoid Arthritis
Slidesets SELECT-MONOTHERAPY Long-Term Extension: Phase III Trial of Upadacitinib in Patients With Rheumatoid Arthritis

Here’s how data from 2019 RA meetings will affect my practice.

Leonard H. Calabrese, DO Released: July 23, 2019

Download slide highlights of the top rheumatoid arthritis studies from these recent conferences.

Leonard H. Calabrese, DO Stanley B. Cohen, MD Paul Emery, MA, MD, FRCP Jonathan Kay, MD Released: July 3, 2019
Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo
Contact Info

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
Gilead Sciences
Lilly
Sanofi Genzyme and Regeneron Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?